UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income		$ 4,496,859	$ 2,480,478
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	$ 2,038,170	(5,300,330)	(3,930,750)
Financing costs - derivative warrant liabilities			449,070
Income from investments held in Trust Account	(1,558,441)	(2,076,393)	(14,175)
Gain from settlement of deferred underwriting commissions on public warrants	(271,688)	(271,688)
Changes in operating assets and liabilities:
Prepaid expenses		103,013	(296,330)
Accounts payable		91,801	47,392
Accrued expenses		2,049,500	(136,250)
Franchise tax payable		(98,031)	100,362
Income tax payable		352,045
Net cash used in operating activities		(653,224)	(1,300,203)
Cash Flows from Investing Activities
Cash deposited in Trust Account			(345,000,000)
Interest released from Trust Account		481,543
Net cash provided by (used in) investing activities		481,543	(345,000,000)
Cash Flows from Financing Activities:
Repayment of note payable			(130,000)
Proceeds received from initial public offering, gross			345,000,000
Proceeds received from private placement			8,900,000
Offering costs paid		(70,000)	(7,143,422)
Net cash (used in) provided by financing activities		(70,000)	346,626,578
Net (decrease) increase in cash		(241,681)	326,375
Cash - beginning of the period		252,601	16,110
Cash - end of the period	$ 10,920	10,920	342,485
Supplemental disclosure of noncash financing activities:
Remeasurement of Class A common stock subject to possible redemption		$ 1,085,953
Offering costs included in accrued expenses			70,000
Deferred underwriting commissions			$ 12,075,000